世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

放射線障害（放射線病、急性放射線症候群）の世界市場に関する洞察と2028年までの予測


Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Insights and Forecast to 2028

市場の分析と洞察。放射線毒性（放射線病、急性放射線症候群）の世界市場 世界の放射線障害（放射線病、急性放射線症候群）市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2022年2月11日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

市場の分析と洞察。放射線毒性（放射線病、急性放射線症候群）の世界市場
世界の放射線障害（放射線病、急性放射線症候群）市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間に年平均成長率（%）で推移する見込みです。
この健康危機による経済変化を十分に考慮し、2021年に放射線毒性（放射線病、急性放射線症候群）世界市場の％を占めた輸血は、2028年までに百万米ドルの価値を持ち、COVID-19後の期間に改訂された％のCAGRで成長すると予測されます。一方、病院セグメントは、この予測期間を通して％CAGRに変更されています。
中国放射線毒性（放射線病、急性放射線症候群）市場規模は2021年に百万米ドル、北米とヨーロッパ放射線毒性（放射線病、急性放射線症候群）はそれぞれ百万米ドル、百万米ドルと評価されています。北米の割合は2021年に％、中国とヨーロッパはそれぞれ％、％であり、中国の割合は2028年に％に達すると予測され、分析期間を通じてCAGRは％を推移しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％である。欧州の放射線毒性（放射線病、急性放射線症候群）については、ドイツが2028年までに100万米ドルに達すると予測され、予測期間中のCAGRは%である。
本レポートは、業界標準の分析精度と高いデータ整合性により、世界の放射線毒性（放射線障害、急性放射線症候群）市場で利用可能な主要機会を明らかにし、プレイヤーが市場で確固たる地位を獲得するのに役立つ素晴らしい試みとなっています。本レポートの購入者は、世界の放射線毒性（放射線障害、急性放射線症候群）市場の全体規模（収益ベース）を含む、検証済みで信頼できる市場予測にアクセスすることができます。
全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界の放射線毒性（放射線病、急性放射線症候群）市場における持続的な成功を確保するために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されたものです。レポートを執筆したアナリストは、世界の放射線毒性（放射線病、急性放射線症候群）市場を詳細に調査するために、ユニークで業界最高の調査および分析アプローチをとりました。

世界の放射線毒性（放射線病、急性放射線症候群）の範囲と市場規模
放射線障害（放射線病、急性放射線症候群）市場は、プレイヤー別、地域（国）別、タイプ別、用途別に分類されます。世界の放射線毒性（放射線病、急性放射線症候群）市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして使用することで、優位に立つことができるようになるでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
輸血
抗生物質
その他
用途別セグメント
病院
クリニック
会社別
アイオロス・ファーマシューティカルズ・インク
アトックスバイオリミテッド
BCNバイオサイエンシズLLC
セルファイア・インク
第一三共株式会社
ファーストストリングリサーチインク
RxBio社
シャトル・ファーマシューティカルズ LLC
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他の欧州地域
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア
ラテンアメリカ
メキシコ
ブラジル
ラテンアメリカの残りの地域
中近東・アフリカ
トルコ
サウジアラビア
UAE
MEAの残りの地域


ページTOPに戻る


目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Blood Transfusion
1.2.3 Antibiotic
1.2.4 Others
1.3 Market by Application
1.3.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Perspective (2017-2028)
2.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Growth Trends by Region
2.2.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Region (2017-2022)
2.2.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Region (2023-2028)
2.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Dynamics
2.3.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Industry Trends
2.3.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Drivers
2.3.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Challenges
2.3.4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Revenue
3.1.1 Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Revenue (2017-2022)
3.1.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Players (2017-2022)
3.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue
3.4 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Ratio
3.4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue in 2021
3.5 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Key Players Head office and Area Served
3.6 Key Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Solution and Service
3.7 Date of Enter into Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Breakdown Data by Type
4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Type (2017-2022)
4.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Type (2023-2028)
5 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Breakdown Data by Application
5.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Application (2017-2022)
5.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
6.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
6.2.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
6.2.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
6.2.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
6.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
6.3.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
6.3.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
6.3.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
6.4 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
6.4.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022)
6.4.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
7.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
7.2.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
7.2.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
7.2.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
7.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
7.3.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
7.3.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
7.3.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
7.4 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
7.4.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022)
7.4.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
8.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
8.2.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
8.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
8.3.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
8.4 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region
8.4.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
9.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
9.2.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
9.2.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
9.2.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
9.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
9.3.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
9.3.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
9.3.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
9.4 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
9.4.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022)
9.4.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
10.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
10.2.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
10.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
10.3.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
10.4 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
10.4.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Aeolus Pharmaceuticals, Inc.
11.1.1 Aeolus Pharmaceuticals, Inc. Company Details
11.1.2 Aeolus Pharmaceuticals, Inc. Business Overview
11.1.3 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.1.4 Aeolus Pharmaceuticals, Inc. Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.1.5 Aeolus Pharmaceuticals, Inc. Recent Developments
11.2 Atox Bio Ltd
11.2.1 Atox Bio Ltd Company Details
11.2.2 Atox Bio Ltd Business Overview
11.2.3 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.2.4 Atox Bio Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.2.5 Atox Bio Ltd Recent Developments
11.3 BCN Biosciences LLC
11.3.1 BCN Biosciences LLC Company Details
11.3.2 BCN Biosciences LLC Business Overview
11.3.3 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.3.4 BCN Biosciences LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.3.5 BCN Biosciences LLC Recent Developments
11.4 Cellphire Inc
11.4.1 Cellphire Inc Company Details
11.4.2 Cellphire Inc Business Overview
11.4.3 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.4.4 Cellphire Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.4.5 Cellphire Inc Recent Developments
11.5 Daiichi Sankyo Co Ltd
11.5.1 Daiichi Sankyo Co Ltd Company Details
11.5.2 Daiichi Sankyo Co Ltd Business Overview
11.5.3 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.5.4 Daiichi Sankyo Co Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.5.5 Daiichi Sankyo Co Ltd Recent Developments
11.6 FirstString Research Inc
11.6.1 FirstString Research Inc Company Details
11.6.2 FirstString Research Inc Business Overview
11.6.3 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.6.4 FirstString Research Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.6.5 FirstString Research Inc Recent Developments
11.7 RxBio Inc
11.7.1 RxBio Inc Company Details
11.7.2 RxBio Inc Business Overview
11.7.3 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.7.4 RxBio Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.7.5 RxBio Inc Recent Developments
11.8 Shuttle Pharmaceuticals LLC
11.8.1 Shuttle Pharmaceuticals LLC Company Details
11.8.2 Shuttle Pharmaceuticals LLC Business Overview
11.8.3 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.8.4 Shuttle Pharmaceuticals LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.8.5 Shuttle Pharmaceuticals LLC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

　

ページTOPに戻る


　

Summary

Market Analysis and Insights: Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
The global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Blood Transfusion accounting for % of the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market size is valued at US$ million in 2021, while the North America and Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market.

Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Scope and Market Size
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Blood Transfusion
Antibiotic
Others
Segment by Application
Hospital
Clinic
By Company
Aeolus Pharmaceuticals, Inc.
Atox Bio Ltd
BCN Biosciences LLC
Cellphire Inc
Daiichi Sankyo Co Ltd
FirstString Research Inc
RxBio Inc
Shuttle Pharmaceuticals LLC
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA



ページTOPに戻る


Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Blood Transfusion
1.2.3 Antibiotic
1.2.4 Others
1.3 Market by Application
1.3.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Perspective (2017-2028)
2.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Growth Trends by Region
2.2.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Region (2017-2022)
2.2.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Region (2023-2028)
2.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Dynamics
2.3.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Industry Trends
2.3.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Drivers
2.3.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Challenges
2.3.4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Revenue
3.1.1 Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Revenue (2017-2022)
3.1.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Players (2017-2022)
3.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue
3.4 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Ratio
3.4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue in 2021
3.5 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Key Players Head office and Area Served
3.6 Key Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Solution and Service
3.7 Date of Enter into Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Breakdown Data by Type
4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Type (2017-2022)
4.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Type (2023-2028)
5 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Breakdown Data by Application
5.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Application (2017-2022)
5.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
6.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
6.2.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
6.2.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
6.2.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
6.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
6.3.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
6.3.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
6.3.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
6.4 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
6.4.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022)
6.4.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
7.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
7.2.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
7.2.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
7.2.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
7.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
7.3.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
7.3.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
7.3.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
7.4 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
7.4.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022)
7.4.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
8.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
8.2.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
8.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
8.3.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
8.4 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region
8.4.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
9.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
9.2.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
9.2.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
9.2.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
9.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
9.3.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
9.3.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
9.3.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
9.4 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
9.4.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022)
9.4.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
10.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
10.2.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
10.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
10.3.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
10.4 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
10.4.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Aeolus Pharmaceuticals, Inc.
11.1.1 Aeolus Pharmaceuticals, Inc. Company Details
11.1.2 Aeolus Pharmaceuticals, Inc. Business Overview
11.1.3 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.1.4 Aeolus Pharmaceuticals, Inc. Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.1.5 Aeolus Pharmaceuticals, Inc. Recent Developments
11.2 Atox Bio Ltd
11.2.1 Atox Bio Ltd Company Details
11.2.2 Atox Bio Ltd Business Overview
11.2.3 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.2.4 Atox Bio Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.2.5 Atox Bio Ltd Recent Developments
11.3 BCN Biosciences LLC
11.3.1 BCN Biosciences LLC Company Details
11.3.2 BCN Biosciences LLC Business Overview
11.3.3 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.3.4 BCN Biosciences LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.3.5 BCN Biosciences LLC Recent Developments
11.4 Cellphire Inc
11.4.1 Cellphire Inc Company Details
11.4.2 Cellphire Inc Business Overview
11.4.3 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.4.4 Cellphire Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.4.5 Cellphire Inc Recent Developments
11.5 Daiichi Sankyo Co Ltd
11.5.1 Daiichi Sankyo Co Ltd Company Details
11.5.2 Daiichi Sankyo Co Ltd Business Overview
11.5.3 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.5.4 Daiichi Sankyo Co Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.5.5 Daiichi Sankyo Co Ltd Recent Developments
11.6 FirstString Research Inc
11.6.1 FirstString Research Inc Company Details
11.6.2 FirstString Research Inc Business Overview
11.6.3 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.6.4 FirstString Research Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.6.5 FirstString Research Inc Recent Developments
11.7 RxBio Inc
11.7.1 RxBio Inc Company Details
11.7.2 RxBio Inc Business Overview
11.7.3 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.7.4 RxBio Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.7.5 RxBio Inc Recent Developments
11.8 Shuttle Pharmaceuticals LLC
11.8.1 Shuttle Pharmaceuticals LLC Company Details
11.8.2 Shuttle Pharmaceuticals LLC Business Overview
11.8.3 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.8.4 Shuttle Pharmaceuticals LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
11.8.5 Shuttle Pharmaceuticals LLC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（中枢神経系作用薬）の最新刊レポート

QYResearch社の中枢神経系作用薬分野での最新刊レポート

本レポートと同じKEY WORD（acute）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14　10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.